These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 8536361

  • 1. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M, Pozniak A, McManus TJ, Vergani D, Peakman M.
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [Abstract] [Full Text] [Related]

  • 2. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL.
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [Abstract] [Full Text] [Related]

  • 3. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S, Jouen-Beades F, Gilbert D, Borsa-Lebas F, Michel Y, Humbert G, Tron F.
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [Abstract] [Full Text] [Related]

  • 4. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    Benito JM, Zabay JM, Gil J, Bermejo M, Escudero A, Sánchez E, Fernández-Cruz E.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb 01; 14(2):128-35. PubMed ID: 9052721
    [Abstract] [Full Text] [Related]

  • 5. Increased level of activated gamma delta lymphocytes correlates with disease severity in HIV infection.
    Norazmi MN, Arifin H, Jamaruddin MA.
    Immunol Cell Biol; 1995 Jun 01; 73(3):245-8. PubMed ID: 7590898
    [Abstract] [Full Text] [Related]

  • 6. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
    Kestens L, Vanham G, Gigase P, Young G, Hannet I, Vanlangendonck F, Hulstaert F, Bach BA.
    AIDS; 1992 Aug 01; 6(8):793-7. PubMed ID: 1418775
    [Abstract] [Full Text] [Related]

  • 7. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.
    J Med Virol; 2016 Aug 01; 88(8):1347-56. PubMed ID: 26765625
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR, Zaunders JJ, Cunningham P, Cooper DA.
    AIDS Res Hum Retroviruses; 1999 Jul 20; 15(11):963-72. PubMed ID: 10445808
    [Abstract] [Full Text] [Related]

  • 9. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M, Rossi ME, Azzari C, Gelli MG, Galli L, Vierucci A.
    Pediatr Res; 1998 Jun 20; 43(6):752-8. PubMed ID: 9621984
    [Abstract] [Full Text] [Related]

  • 10. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV, Ho HN, Hirji K, Chou CC, Hultin LE, O'Rourke S, Park L, Margolick JB, Ferbas J, Phair JP.
    J Infect Dis; 1994 Oct 20; 170(4):775-81. PubMed ID: 7930717
    [Abstract] [Full Text] [Related]

  • 11. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
    Echaniz P, Arrizabalaga J, Iribarren JA, Cuadrado E.
    Cell Immunol; 1993 Aug 20; 150(1):72-80. PubMed ID: 7688270
    [Abstract] [Full Text] [Related]

  • 12. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC.
    J Acquir Immune Defic Syndr; 1999 Sep 01; 22(1):19-30. PubMed ID: 10534143
    [Abstract] [Full Text] [Related]

  • 13. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G.
    AIDS; 1996 Jul 01; 10(8):827-34. PubMed ID: 8828739
    [Abstract] [Full Text] [Related]

  • 14. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B.
    AIDS; 1999 Dec 03; 13(17):2365-76. PubMed ID: 10597778
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
    Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R.
    J Acquir Immune Defic Syndr (1988); 1993 Aug 03; 6(8):904-12. PubMed ID: 7686224
    [Abstract] [Full Text] [Related]

  • 16. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.
    Islam D, Bardhan PK, Lindberg AA, Christensson B.
    Infect Immun; 1995 Aug 03; 63(8):2941-9. PubMed ID: 7622216
    [Abstract] [Full Text] [Related]

  • 17. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct 01; 16(2):83-92. PubMed ID: 9358102
    [Abstract] [Full Text] [Related]

  • 18. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R, Bratt G, Holmberg V, Muirhead K, Sandström E.
    Cytometry; 1998 Oct 01; 33(2):115-22. PubMed ID: 9773871
    [Abstract] [Full Text] [Related]

  • 19. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
    Hua S, Lécuroux C, Sáez-Cirión A, Pancino G, Girault I, Versmisse P, Boufassa F, Taulera O, Sinet M, Lambotte O, Venet A.
    PLoS One; 2014 Oct 01; 9(7):e101920. PubMed ID: 25000587
    [Abstract] [Full Text] [Related]

  • 20. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou CC, O'Rourke S, Taylor JM, Giorgi JV.
    J Immunol; 1993 Apr 01; 150(7):3070-9. PubMed ID: 8454874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.